Motoshi Kawashima

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki et al. · The Lancet Neurology · 2010 · 187 citations

Jasmitt Study, Clinical Injury, Neurological Disorder +10

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki et al. · Annals of Neurology · 2009 · 156 citations

Walking capacity evaluated by the 6‐minute walk test in spinal and bulbar muscular atrophy

Yu Takeuchi, Masahisa Katsuno, Haruhiko Banno et al. · Muscle & Nerve · 2008 · 62 citations

Physical Activity, Movement Biomechanics, Neurochemical Biomarkers +19

Subjects at risk of Parkinson’s disease in health checkup examinees: cross-sectional analysis of baseline data of the NaT-PROBE study

Makoto Hattori, Takashi Tsuboi, Katsunori Yokoi et al. · Journal of Neurology · 2020 · 20 citations

Neurodegenerative Diseases, Health Checkup Examinees, Parkinson Disease +7

Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis

Makoto Hattori, Keita Hiraga, Yuki Satake et al. · npj Parkinson s Disease · 2023 · 14 citations · Full text